Literature DB >> 10733552

Proliferation of hepatic lineage cells of normal C57BL and interleukin-6 knockout mice after cocaine-induced periportal injury.

D Rosenberg1, Z Ilic, L Yin, S Sell.   

Abstract

The cellular response to periportal liver injury, induced by phenobarbital feeding and cocaine injection, is used to compare the restitutive proliferation of hepatocytes, cholangiocytes, and oval cells in the livers of normal control to those of interleukin-6 (IL-6) knockout mice. After this injury hepatocytes in noninjured middle and central zones start to proliferate first, followed by proliferation of cholangiocytes and intraportal oval cells. Proliferation of all cell types peaks at 2 days, but oval cells continue to proliferate and differentiate through days 4 and 6 as they reconstitute the necrotic zone. By day 10, the injured zone is completely repaired, and no dividing cells remain. During the first 3 to 4 days after injury, the number of proliferating hepatocytes, cholangiocytes, and sinusoidal cells is lower in IL-6 knockout mice than in normal mice, whereas the number of dividing oval cells is higher. However, overall repair of the injury is accomplished in the same time period in both groups. During repair of the periportal zone, oval cells acquire differentiation markers of hepatocytes as they cross the zone of injury. In conclusion, the phenobarbital/cocaine injury model is useful to study restitutive proliferation of mouse liver cell lineages. The proliferative response in IL-6 knockout mice shows that IL-6 is not required for proliferation of liver cells; timely repair of liver injury occurs in both normal and IL-6 knockout mice. Increased proliferation of oval cells in IL-6 knockout mice may compensate for the lower proliferation of other liver cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733552     DOI: 10.1053/he.2000.5410

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Immunohistochemical study of hepatic oval cells in human chronic viral hepatitis.

Authors:  X Ma; D K Qiu; Y S Peng
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice.

Authors:  Dana R Crawford; Stephanie Ostrowski; Dilip Vakharia; Zoran Ilic; Stewart Sell
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Localized hepatic lobular regeneration by central-vein-associated lineage-restricted progenitors.

Authors:  Jonathan M Tsai; Pang Wei Koh; Ania Stefanska; Liujing Xing; Graham G Walmsley; Nicolas Poux; Irving L Weissman; Yuval Rinkevich
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-22       Impact factor: 11.205

4.  Hepatic progenitor cell activation in liver repair.

Authors:  Adam Bria; Jorgessen Marda; Junmei Zhou; Xiaowei Sun; Qi Cao; Bryon E Petersen; Liya Pi
Journal:  Liver Res       Date:  2017-08-09

Review 5.  Liver development, regeneration, and carcinogenesis.

Authors:  Janet W C Kung; Ian S Currie; Stuart J Forbes; James A Ross
Journal:  J Biomed Biotechnol       Date:  2010-02-07

Review 6.  Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.

Authors:  Stewart Sell
Journal:  Tumour Biol       Date:  2008-07-09

Review 7.  Stem cells and liver regeneration.

Authors:  Andrew W Duncan; Craig Dorrell; Markus Grompe
Journal:  Gastroenterology       Date:  2009-05-24       Impact factor: 22.682

Review 8.  Activation of stem cells in hepatic diseases.

Authors:  T G Bird; S Lorenzini; S J Forbes
Journal:  Cell Tissue Res       Date:  2007-11-29       Impact factor: 5.249

Review 9.  Stem cells, cell transplantation and liver repopulation.

Authors:  Michael Oertel; David A Shafritz
Journal:  Biochim Biophys Acta       Date:  2007-12-23

Review 10.  New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.

Authors:  Maria D Giraldez; David Carneros; Christoph Garbers; Stefan Rose-John; Matilde Bustos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-01       Impact factor: 46.802

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.